RNS Number:0964K
PPL Therapeutics PLC
16 April 2003





For the attention of Company Announcements, London Stock Exchange







On Monday 28 April 2003, PPL Therapeutics plc, a leading company in the
application of transgenic technology to the production of human proteins for
therapeutic applications, will be announcing its preliminary results for the
year ended 31 December 2002.



An analyst briefing will be held at the offices of Hudson Sandler on Monday 28
April 2003, for further information please contact:



Alistair Mackinnon-Musson

Philip Dennis

Hudson Sandler

Tel:  020 7796 4133

e-mail:  ppl@hspr.co.uk








                      This information is provided by RNS
            The company news service from the London Stock Exchange
END

NORFGGMDLVDGFZG